Imagine a single injection into the knee vanquishing painful arthritis – forever. Gene therapies aimed at two molecular targets will likely make that possible, with one, Invossa, already approved in South Korea.
“Arthritis” is a catch-all term for more than 100 varieties of joint inflammation. In the US, more than 30 million people have osteoarthritis (OA). The knee is particularly vulnerable, with arthritis there plaguing 10% of men and 13% of women aged 60 years or older.
Four events contribute to arthritis: inflammation, an increase in the volume of synovial fluid that fills joints, breakdown of the joint, and underlying bone damage. Read More
“Arthritis” is a catch-all term for more than 100 varieties of joint inflammation. In the US, more than 30 million people have osteoarthritis (OA). The knee is particularly vulnerable, with arthritis there plaguing 10% of men and 13% of women aged 60 years or older.
Four events contribute to arthritis: inflammation, an increase in the volume of synovial fluid that fills joints, breakdown of the joint, and underlying bone damage. Read More